Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 585.58 K | $230.72 K | -1.49% | 2.32% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 449.96 K | $177.29 K | -30.77% | 1.79% |
05/15/2025 | 294.37 K | $115.98 K | 0.00% | 1.17% | |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 177.30 K | $69.86 K | 13.07% | 0.70% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 150.71 K | $59.39 K | 1.22% | 0.60% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 108.66 K | $42.81 K | -37.12% | 0.43% |
UBS GROUP AG | 05/13/2025 | 42.54 K | $16.76 K | 2,126,950.00% | 0.17% |
NORTHERN TRUST CORP | 05/13/2025 | 25.98 K | $10.24 K | 0.00% | 0.10% |
STATE STREET CORP | 05/15/2025 | 25.77 K | $10.16 K | 0.00% | 0.10% |
CRESSET ASSET MANAGEMENT, LLC | 05/13/2025 | 19.67 K | $7.75 K | 0.00% | 0.08% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 14.00 K | $5.52 K | 0.00% | 0.06% |
MORGAN STANLEY | 05/15/2025 | 9.22 K | $3.63 K | 0.00% | 0.04% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 5.40 K | $2.13 K | -0.81% | 0.02% |
BARCLAYS PLC | 05/15/2025 | 2.56 K | $1.00 K | 100.00% | 0.01% |
JPMORGAN CHASE & CO | 05/12/2025 | 702 | $276 | -0.43% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 160 | $63 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 142 | $56 | 4.41% | 0.00% |
CITIGROUP INC | 05/12/2025 | 124 | $49 | 100.00% | 0.00% |
05/02/2025 | 92 | $36 | 29.58% | 0.00% | |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
DEUTERIUM CAPITAL MANAGEMENT, LLC | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
Sensei Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 585,576
Ikarian Capital, LLC: 449,963
RENAISSANCE TECHNOLOGIES LLC: 177,300
GEODE CAPITAL MANAGEMENT, LLC: 150,709
BOOTHBAY FUND MANAGEMENT, LLC: 108,658
UBS Group AG: 42,541
7.59% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.66 M shares in the last 24 months. This purchase volume represents approximately $14.99 M in transactions.